BRIEF published on 09/18/2024 at 20:05, 1 year 9 months ago Levée de fonds de 0,25 M€ par Néovacs Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
PRESS RELEASE published on 09/18/2024 at 20:00, 1 year 9 months ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ via l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et investir dans des projets prometteurs en Biotech et MedTech Biotech Levée De Fonds Néovacs OCEANE-BSA Recherche Allergies
BRIEF published on 08/28/2024 at 23:05, 1 year 9 months ago Adjustment of the nominal value: Neovacs reduces its capital Financial Health Euronext Growth Capital Reduction Nominal Value Néovacs
BRIEF published on 08/28/2024 at 23:05, 1 year 9 months ago Ajustement de la valeur nominale : Néovacs réduit son capital Euronext Growth Réduction De Capital Santé Financière Valeur Nominale Néovacs
PRESS RELEASE published on 08/28/2024 at 23:00, 1 year 9 months ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 0,005 € à 0,0005 € suite à une réduction de capital. La société biopharmaceutique développe des thérapies pour des maladies inflammatoires et auto-immunes Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 11 months ago Termination of the financing contract granted to Pharnext Termination Funding Biopharmaceutical Pharnext Néovacs
BRIEF published on 07/04/2024 at 20:05, 1 year 11 months ago Résiliation du contrat de financement accordé à Pharnext Financement Biopharmaceutique Pharnext Résiliation Néovacs
PRESS RELEASE published on 07/04/2024 at 20:00, 1 year 11 months ago Résiliation du contrat de financement accordé à Pharnext Résiliation du contrat de financement entre Néovacs et Pharnext, suite à des cas de défaut. Le fiduciaire demande le remboursement anticipé de 22 M€. Détails sur les sûretés en place Financement Pharnext Résiliation Néovacs Fiduciaire
BRIEF published on 06/17/2024 at 08:05, 2 years ago Néovacs collaborates with the CNRS to develop mRNA lipid formulations Scientific Collaboration Biomedical Research Néovacs CNRS Lipid Formulations Messenger RNA
BRIEF published on 06/17/2024 at 08:05, 2 years ago Néovacs collabore avec le CNRS pour développer des formulations lipidiques ARNm Collaboration Scientifique Recherche Biomédicale Formulations Lipidiques ARN Messager Néovacs CNRS
Published on 06/26/2026 at 01:40, 6 hours 49 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 8 hours 59 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 9 hours 59 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 10 hours 57 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 16 hours 59 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 08:00, 29 minutes ago MHM Corporate: Debt Restructuring through Bonds Redeemable in Shares
Published on 06/26/2026 at 08:00, 29 minutes ago MHM Corporate: Restructuration de sa dette par voie d'obligations remboursables en actions
Published on 06/26/2026 at 07:30, 59 minutes ago REINET INVESTMENTS S.C.A. ANNOUNCES REVISED DATE FOR ANNUAL GENERAL MEETING
Published on 06/26/2026 at 07:30, 59 minutes ago THE NAGA GROUP AG CONFIRMS FY 2025 REVENUES AND REPORTS STRONGER-THAN-EXPECTED EBITDA
Published on 06/26/2026 at 07:30, 59 minutes ago Pyrum Innovations AG reports results for the first three months of 2026
Published on 06/26/2026 at 07:00, 1 hour 29 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 1 hour 29 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 13 hours 44 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 13 hours 59 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 14 hours 39 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
